Pill

Ranbaxy to Make Generic Diovan Drug in US

Ranbaxy Laboratories Ltd has received the nod to launch a cheaper version of Novartis AG's blood pressure and heart attack treatment pill Diovan, from US Food and Drug Administration (FDA), amid acquisition process by Sunpharma for $4 billion. Jun 27, 2014